We conducted a systematic meta-analysis of 30 studies involving 3,287 patients with postoperative NSCLC to evaluate the diagnostic performance of ctDNA-based MRD testing for recurrence detection and ...
Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...
Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...
Utility of pre- and post-pembrolizumab (Pembro) Vesical Imaging–Reporting and Data System (VIRADS) to predict the pathological response in muscle-invasive urothelial bladder cancer (MIBC): An analysis ...
Regular monitoring can help identify signs of thyroid cancer recurrence. Many treatment options can help treat recurrent thyroid cancer. The thyroid uses the mineral iodine to produce essential ...
Oral cancer may recur where it initially started or elsewhere in the body. The recurrence rates differ for people with early and advanced stages of oral cancer. Oral cancer can occur anywhere in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results